NanoViricides (NNVC) Earnings Date & Reports

Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

NNVC is expected to report earnings to fall 48.48% to -17 cents per share on August 30

NanoViricides NNVC Stock Earnings Reports

Q2'23

Est.

$-0.17

Q1'24

Missed

by $0.18

Q4'23

Missed

by $0.01

Q3'23

Est.

$-0.17

Q1'23

Est.

$-0.15

The last earnings report on May 14 showed earnings per share of -33 cents, missing the estimate of -15 cents. With 27.14K shares outstanding, the current market capitalization sits at 17.99M.

View a ticker or compare two or three

Compare

NNVC